research and development
Editas Medicine, BMS Extend R&D Collaboration for Cancer, Autoimmune Cell Therapies
As part of the deal, BMS has the option to use Editas' genome-editing tools to develop autologous gene-edited alpha-beta T-cell therapies.
PMV Pharmaceuticals to Lay off 30 Percent of Workforce
The firm said it will reduce its workforce in an effort to streamline its focus on developing its lead oncology candidate PC14586.
Perspective Therapeutics Aiming to Raise up to $80.8 Million in Public Offering, Private Placement
The firm will use the proceeds to advance its lead-212radiopharmaceuticals, including those in trials for advanced neuroendocrine cancer and melanoma.
Octave Bioscience to Conduct Real-World Multiple Sclerosis Study Using Management Platform
The 150-patient, Biogen-sponsored study will use Octave's Precision Care Solution platform to better understand how MS progresses.
Precision Oncology Drugs Cost $1B Less to Develop Than Traditional Therapies, Study Suggests
Premium
Researchers suggested that the savings companies incur by using a precision medicine approach could be reinvested to improve access to companion tests and ensure equitable drug pricing.
Sep 15, 2020
May 27, 2020
Apr 10, 2019
Apr 2, 2019
Mar 31, 2019